Alcohol Abuse and HIV-mediated Neurotoxicity
酒精滥用和艾滋病毒介导的神经毒性
基本信息
- 批准号:8410167
- 负责人:
- 金额:$ 33.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-09-10 至 2017-06-30
- 项目状态:已结题
- 来源:
- 关键词:AIDS Dementia ComplexAIDS/HIV problemAddressAffectAgonistAlcohol abuseAlcohol consumptionAlcohol dependenceAlcoholsAmericanApoptosisAstrocytesBiological ModelsBlood - brain barrier anatomyBrainCCL2 geneCCL3 geneCCL4 geneCXCL10 geneCell Adhesion MoleculesCellsDevelopmentDiseaseDisease ProgressionEthanol MetabolismExtravasationGlutamatesHIVHIV Envelope Protein gp120HIV SeropositivityHIV-1HealthHumanIL8 geneIn VitroIndividualInflammatoryInterleukin-8InterleukinsKnowledgeLaboratoriesMeasuresMediatingMusNeuraxisNeurocognitiveNeurologic ManifestationsNeuronal PlasticityNeuronsOxidative StressPPAR gammaPermeabilityPeroxisome Proliferator-Activated ReceptorsPopulationPrevalenceProductionPropertyPublic HealthRANTESRNAReportingRoleSmall Interfering RNATNF geneTestingTransfectionTransgenic MiceUnited StatesViralViral GenesViral Proteinsalcohol effectalcohol exposurechemokinechronic alcohol ingestioncytokinedesignextracellularin vivoin vivo Modelmouse modelneuroinflammationneuron apoptosisneurotoxicneurotoxicityresearch studytissue culturevirotoxins
项目摘要
DESCRIPTION (provided by applicant):
Alcohol abuse remains one of the major health problems with approximately 14 million Americans (<5% of total population) suffering from alcohol abuse. However, the prevalence of chronic alcohol consumption among HIV-positive individuals has been reported to be between 29 and 60% in US. In view of emerging results from several laboratories, it is becoming clear that alcohol abuse contributes to HIV replication, disease progression and development of HIV-associated dementia. Furthermore both alcohol and HIV are independently known to be neurotoxic, but it is not known with certainty whether they will have synergistic effect in alcohol
addicted HIV-1 positive individuals and cause increased production of proinflammatory. This application is designed to address this gap in the existing knowledge. We will study the combined effect of the alcohol and 2 virotoxins (HIV-1 gp120 and Tat,) on cytokine as well chemokine production, markers of oxidative stress, apoptosis, PPAR-? in astrocytes/neurons, and whether these detrimental effects can be abrogated by use of the antagonists of alcohol metabolism, the virotoxin-specific siRNAs and PPAR-? agonists. These in vitro studies will be extended to in vivo situation where effect of chronic alcohol consumption will be studied in HIV-1 Tat and gp120 transgenic mice. These mice will be used for assessment of cytokine and chemokine expression, neuronal apoptosis in brain as well as leakage in the blood brain barrier and whether use of alcohol antagonist and PPAR-? agonists will abrogate the alcohol-mediated neurotoxicity.
PUBLIC HEALTH RELEVANCE:
This application proposes to dissect mechanism of increased neuroinflammation in alcohol-dependent HIV-1-infected individuals. We will study the role of proinflammatory cytokines and chemokine and whether their over-expression in the CNS leads to increased neurotoxicity. We will also determine role of antagonist of alcohol metabolism, siRNA and PPAR-gamma agonists in the management of neuroinflammation. These in vitro results will be extended to an in vivo model system using transgenic mice.
描述(由申请人提供):
酗酒仍然是大约1400万美国人(占总人口的5%)遭受酗酒的主要健康问题之一。然而,据报道,在美国,HIV阳性个体中长期饮酒的患病率在29%至60%之间。鉴于几个实验室的新兴结果,很明显,酗酒有助于HIV复制,疾病进展和与HIV相关痴呆的发育。此外,酒精和艾滋病毒都是独立的神经毒性的,但尚不确定它们是否会在酒精中具有协同作用
上瘾的HIV-1阳性个体并导致促炎的产生增加。该应用程序旨在解决现有知识中的这一差距。我们将研究酒精和2种病毒毒素(HIV-1 GP120和TAT)对细胞因子以及趋化因子产生,氧化应激,凋亡,PPAR-的标志的综合作用。在星形胶质细胞/神经元中,以及这些有害作用是否可以通过使用酒精代谢的拮抗剂,病毒毒素特异性siRNA和PPAR-的拮抗剂来消除。激动剂。这些体外研究将扩展到体内状况,其中将在HIV-1 TAT和GP120转基因小鼠中研究慢性饮酒的作用。这些小鼠将用于评估细胞因子和趋化因子表达,脑中神经元细胞凋亡以及血脑屏障中的泄漏以及是否使用酒精拮抗剂和PPAR-?激动剂将废除酒精介导的神经毒性。
公共卫生相关性:
该应用建议剖析酒精依赖性HIV-1感染者神经炎症增加的机制。我们将研究促炎细胞因子和趋化因子的作用,以及它们在中枢神经系统中的过表达是否导致神经毒性增加。我们还将确定酒精代谢,siRNA和PPAR-GAMMA激动剂在神经炎症管理中的作用。这些体外结果将扩展到使用转基因小鼠的体内模型系统。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANIL KUMAR其他文献
ANIL KUMAR的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANIL KUMAR', 18)}}的其他基金
Alcohol Abuse and HIV-mediated Neurotoxicity
酒精滥用和艾滋病毒介导的神经毒性
- 批准号:
8867951 - 财政年份:2012
- 资助金额:
$ 33.75万 - 项目类别:
Alcohol Abuse and HIV-mediated Neurotoxicity
酒精滥用和艾滋病毒介导的神经毒性
- 批准号:
8627726 - 财政年份:2012
- 资助金额:
$ 33.75万 - 项目类别:
Alcohol Abuse and HIV-mediated Neurotoxicity
酒精滥用和艾滋病毒介导的神经毒性
- 批准号:
8692615 - 财政年份:2012
- 资助金额:
$ 33.75万 - 项目类别:
Alcohol Abuse and HIV-mediated Neurotoxicity
酒精滥用和艾滋病毒介导的神经毒性
- 批准号:
8542738 - 财政年份:2012
- 资助金额:
$ 33.75万 - 项目类别:
Methamphetamine and AIDS in a Non-Human Primate Model
非人类灵长类动物模型中的甲基苯丙胺和艾滋病
- 批准号:
8652443 - 财政年份:2008
- 资助金额:
$ 33.75万 - 项目类别:
相似海外基金
Role of extracellular vesicles in methamphetamine and HIV induced neurotoxicity
细胞外囊泡在甲基苯丙胺和 HIV 诱导的神经毒性中的作用
- 批准号:
9929090 - 财政年份:2018
- 资助金额:
$ 33.75万 - 项目类别:
CSF & Blood Exosomal microRNAs, Immune Responses, and HAND in ART Suppressed HIV
脑脊液
- 批准号:
9264601 - 财政年份:2016
- 资助金额:
$ 33.75万 - 项目类别:
Adaptive Strategies for Preventing & Treating Lapses of Retention in Care (AdaPT)
适应性预防策略
- 批准号:
9102262 - 财政年份:2014
- 资助金额:
$ 33.75万 - 项目类别:
Mir-125b/p53/POX axis and HIV-1 induced neurological damage
Mir-125b/p53/POX 轴和 HIV-1 诱导的神经损伤
- 批准号:
8927599 - 财政年份:2014
- 资助金额:
$ 33.75万 - 项目类别:
Adaptive Strategies for Preventing & Treating Lapses of Retention in Care (AdaPT)
适应性预防策略
- 批准号:
9315217 - 财政年份:2014
- 资助金额:
$ 33.75万 - 项目类别: